On Monday, October 7, 2024, the U.S. Supreme Court declined to consider a petition for certiorari in United States ex rel. Hart v. McKesson Corp., Case No. 23-1293, where relator, Adam Hart (“Relator”), sought review of a...more
10/16/2024
/ Anti-Kickback Statute ,
Certiorari ,
Denial of Certiorari ,
Healthcare Fraud ,
McKesson Technologies ,
Mens Rea ,
Petition for Writ of Certiorari ,
Pharmaceutical Industry ,
Qui Tam ,
Relators ,
SCOTUS ,
Statutory Violations ,
Willful Misconduct
Arizona has joined two other states in applying its consumer fraud law to pharmaceutical manufacturers. The Arizona Court of Appeals decision came in a products liability action against Medicis Corporation, related to a...more